Consistent with previous reports (34–37), COVID-19 patients displayed higher levels of TNFα, IL-1β, IL-6, IFNα, IFNβ, TGFβ and IL-10 in comparison with HD. This evidence concerns the gene IFNA1 and Huntington disease.